Annual Current Liabilities
$2.21 B
-$809.00 M-26.83%
December 31, 2024
Summary
- As of February 20, 2025, MRNA annual total current liabilities is $2.21 billion, with the most recent change of -$809.00 million (-26.83%) on December 31, 2024.
- During the last 3 years, MRNA annual current liabilities has fallen by -$6.92 billion (-75.83%).
- MRNA annual current liabilities is now -75.83% below its all-time high of $9.13 billion, reached on December 31, 2021.
Performance
MRNA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.21 B
+$5.00 M+0.23%
December 31, 2024
Summary
- As of February 20, 2025, MRNA quarterly total current liabilities is $2.21 billion, with the most recent change of +$5.00 million (+0.23%) on December 31, 2024.
- Over the past year, MRNA quarterly current liabilities has dropped by -$809.00 million (-26.83%).
- MRNA quarterly current liabilities is now -77.84% below its all-time high of $9.96 billion, reached on September 30, 2021.
Performance
MRNA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MRNA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.8% | -26.8% |
| 3 y3 years | -75.8% | -26.8% |
| 5 y5 years | +1441.4% | -26.8% |
MRNA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.8% | at low | -76.1% | +0.2% |
| 5 y | 5-year | -75.8% | +1441.4% | -77.8% | +1539.2% |
| alltime | all time | -75.8% | >+9999.0% | -77.8% | >+9999.0% |
Moderna Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.21 B(-26.8%) | $2.21 B(+0.2%) |
| Sep 2024 | - | $2.20 B(-6.9%) |
| Jun 2024 | - | $2.36 B(-0.7%) |
| Mar 2024 | - | $2.38 B(-21.1%) |
| Dec 2023 | $3.02 B(-38.8%) | $3.02 B(-31.2%) |
| Sep 2023 | - | $4.38 B(+40.4%) |
| Jun 2023 | - | $3.12 B(-10.7%) |
| Mar 2023 | - | $3.50 B(-28.9%) |
| Dec 2022 | $4.92 B(-46.1%) | $4.92 B(-27.7%) |
| Sep 2022 | - | $6.81 B(-0.1%) |
| Jun 2022 | - | $6.81 B(-26.3%) |
| Mar 2022 | - | $9.24 B(+1.2%) |
| Dec 2021 | $9.13 B(+108.0%) | $9.13 B(-8.3%) |
| Sep 2021 | - | $9.96 B(+12.6%) |
| Jun 2021 | - | $8.84 B(+4.7%) |
| Mar 2021 | - | $8.44 B(+92.3%) |
| Dec 2020 | $4.39 B(+2966.8%) | $4.39 B(+197.8%) |
| Sep 2020 | - | $1.47 B(+811.6%) |
| Jun 2020 | - | $161.65 M(+20.1%) |
| Mar 2020 | - | $134.58 M(-6.0%) |
| Dec 2019 | $143.12 M(-35.8%) | $143.12 M(-3.2%) |
| Sep 2019 | - | $147.84 M(-8.7%) |
| Jun 2019 | - | $161.99 M(+1.8%) |
| Mar 2019 | - | $159.16 M(-28.6%) |
| Dec 2018 | $222.80 M(+16.4%) | $222.80 M(+19.5%) |
| Sep 2018 | - | $186.42 M(-2.6%) |
| Dec 2017 | $191.46 M(+17.6%) | $191.46 M(+4049.1%) |
| Sep 2017 | - | $4.61 M(+11.0%) |
| Jun 2017 | - | $4.16 M(+54.1%) |
| Mar 2017 | - | $2.70 M(-9.1%) |
| Dec 2016 | $162.80 M(+6583.2%) | - |
| Dec 2016 | - | $2.97 M(-1.3%) |
| Sep 2016 | - | $3.01 M(-3.2%) |
| Jun 2016 | - | $3.11 M(+9.1%) |
| Mar 2016 | - | $2.85 M(+17.0%) |
| Dec 2015 | $2.44 M(+25.4%) | $2.44 M(-2.3%) |
| Sep 2015 | - | $2.49 M(+17.5%) |
| Jun 2015 | - | $2.12 M(+14.3%) |
| Mar 2015 | - | $1.86 M(-4.4%) |
| Dec 2014 | $1.94 M(-68.8%) | $1.94 M(-14.8%) |
| Sep 2014 | - | $2.28 M(+12.6%) |
| Jun 2014 | - | $2.02 M(-25.1%) |
| Mar 2014 | - | $2.70 M(-56.5%) |
| Dec 2013 | $6.22 M(+10.5%) | $6.22 M(+7.3%) |
| Sep 2013 | - | $5.79 M(+3.8%) |
| Jun 2013 | - | $5.58 M(+2.9%) |
| Mar 2013 | - | $5.43 M(-3.6%) |
| Dec 2012 | $5.63 M(+21.3%) | $5.63 M(+1.6%) |
| Sep 2012 | - | $5.54 M(-13.4%) |
| Jun 2012 | - | $6.40 M(+14.2%) |
| Mar 2012 | - | $5.60 M(+20.8%) |
| Dec 2011 | $4.64 M(-26.1%) | $4.64 M(+8.3%) |
| Sep 2011 | - | $4.28 M(-38.0%) |
| Jun 2011 | - | $6.91 M(+9.4%) |
| Mar 2011 | - | $6.32 M(+0.7%) |
| Dec 2010 | $6.27 M(+22.3%) | $6.27 M(+22.3%) |
| Sep 2010 | - | $5.13 M(-38.2%) |
| Jun 2010 | - | $8.30 M(+56.4%) |
| Mar 2010 | - | $5.31 M(+3.5%) |
| Dec 2009 | $5.13 M | $5.13 M(+40.7%) |
| Sep 2009 | - | $3.65 M(+4.2%) |
| Jun 2009 | - | $3.50 M(-50.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $7.05 M(-43.7%) |
| Dec 2008 | $12.52 M(-7.7%) | $12.52 M(+14.8%) |
| Sep 2008 | - | $10.91 M(+10.3%) |
| Jun 2008 | - | $9.89 M(-15.9%) |
| Mar 2008 | - | $11.76 M(-13.3%) |
| Dec 2007 | $13.57 M(-7.9%) | $13.57 M(-9.5%) |
| Sep 2007 | - | $14.99 M(+11.3%) |
| Jun 2007 | - | $13.47 M(-1.1%) |
| Mar 2007 | - | $13.62 M(-7.5%) |
| Dec 2006 | $14.72 M(+60.4%) | $14.72 M(+5.5%) |
| Sep 2006 | - | $13.96 M(+11.5%) |
| Jun 2006 | - | $12.52 M(+11.4%) |
| Mar 2006 | - | $11.24 M(+22.5%) |
| Dec 2005 | $9.18 M(-45.5%) | $9.18 M(+3.1%) |
| Sep 2005 | - | $8.90 M(-15.0%) |
| Jun 2005 | - | $10.47 M(+17.2%) |
| Mar 2005 | - | $8.94 M(-46.9%) |
| Dec 2004 | $16.84 M(+52.2%) | $16.84 M(+15.2%) |
| Sep 2004 | - | $14.62 M(+11.2%) |
| Jun 2004 | - | $13.14 M(+3.1%) |
| Mar 2004 | - | $12.75 M(+15.2%) |
| Dec 2003 | $11.07 M(+56.7%) | $11.07 M(-7.3%) |
| Sep 2003 | - | $11.94 M(-3.7%) |
| Jun 2003 | - | $12.41 M(-8.1%) |
| Mar 2003 | - | $13.50 M(+91.2%) |
| Dec 2002 | $7.06 M(+268.6%) | $7.06 M(-17.2%) |
| Sep 2002 | - | $8.53 M(+80.0%) |
| Jun 2002 | - | $4.74 M(+28.9%) |
| Mar 2002 | - | $3.68 M(+91.9%) |
| Dec 2001 | $1.92 M(-8.6%) | $1.92 M(+6.9%) |
| Sep 2001 | - | $1.79 M(-4.0%) |
| Jun 2001 | - | $1.87 M(-15.1%) |
| Mar 2001 | - | $2.20 M(+4.8%) |
| Dec 2000 | $2.10 M(-41.8%) | $2.10 M(-12.2%) |
| Sep 2000 | - | $2.39 M(-0.0%) |
| Jun 2000 | - | $2.39 M(+26.2%) |
| Mar 2000 | - | $1.89 M(-47.4%) |
| Dec 1999 | $3.60 M(+80.0%) | $3.60 M(+44.0%) |
| Sep 1999 | - | $2.50 M(+25.0%) |
| Jun 1999 | - | $2.00 M(-13.0%) |
| Mar 1999 | - | $2.30 M(+15.0%) |
| Dec 1998 | $2.00 M(-16.7%) | $2.00 M(-4.8%) |
| Sep 1998 | - | $2.10 M(-4.5%) |
| Jun 1998 | - | $2.20 M(+29.4%) |
| Mar 1998 | - | $1.70 M(-29.2%) |
| Dec 1997 | $2.40 M(+118.2%) | $2.40 M(+33.3%) |
| Sep 1997 | - | $1.80 M(+5.9%) |
| Jun 1997 | - | $1.70 M(+21.4%) |
| Mar 1997 | - | $1.40 M(+55.6%) |
| Dec 1996 | $1.10 M(-35.3%) | - |
| Sep 1996 | - | $900.00 K(-47.1%) |
| Jun 1996 | $1.70 M(0.0%) | $1.70 M(+30.8%) |
| Mar 1996 | - | $1.30 M(0.0%) |
| Dec 1995 | - | $1.30 M(-13.3%) |
| Sep 1995 | - | $1.50 M(-11.8%) |
| Jun 1995 | $1.70 M(+41.7%) | $1.70 M(+41.7%) |
| Mar 1995 | - | $1.20 M(+9.1%) |
| Dec 1994 | - | $1.10 M(-8.3%) |
| Sep 1994 | - | $1.20 M(0.0%) |
| Jun 1994 | $1.20 M | $1.20 M(+20.0%) |
| Mar 1994 | - | $1.00 M(-9.1%) |
| Dec 1993 | - | $1.10 M(+10.0%) |
| Sep 1993 | - | $1.00 M |
FAQ
- What is Moderna annual total current liabilities?
- What is the all time high annual current liabilities for Moderna?
- What is Moderna annual current liabilities year-on-year change?
- What is Moderna quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Moderna?
- What is Moderna quarterly current liabilities year-on-year change?
What is Moderna annual total current liabilities?
The current annual current liabilities of MRNA is $2.21 B
What is the all time high annual current liabilities for Moderna?
Moderna all-time high annual total current liabilities is $9.13 B
What is Moderna annual current liabilities year-on-year change?
Over the past year, MRNA annual total current liabilities has changed by -$809.00 M (-26.83%)
What is Moderna quarterly total current liabilities?
The current quarterly current liabilities of MRNA is $2.21 B
What is the all time high quarterly current liabilities for Moderna?
Moderna all-time high quarterly total current liabilities is $9.96 B
What is Moderna quarterly current liabilities year-on-year change?
Over the past year, MRNA quarterly total current liabilities has changed by -$809.00 M (-26.83%)